Translational Development Acquisition Corp Files Proxy Statement for Shareholder Meeting AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests Klaviyo Expands Anthropic Partnership to Deploy Agentic Marketing Workflows on Claude Tulsi Gabbard Resigns as Director of National Intelligence Marking Latest Cabinet Departure Ferraris Strategic Bet Luce FiveSeat EV Targets Generational Technology Shift Consumer Sentiment Plunges to Record Low in May as Iran Conflict Drives Gas Prices Higher OTTR Q1 2026 Earnings Earnings Beat Estimates as EPS Surges 1986 Above Consensus Marten Transport Q1 2026 Earnings Small EPS Beat Amidst Challenging Freight Environment TriplePoint Venture Growth BDC Corp TPVG Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Resilient Portfolio Live Ventures Q1 2026 Earnings Diversified Holding Company Reports Positive EPS Amid Market Challenges CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge VAL Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Offshore Drilling Market Alphatec Holdings ATEC Slides 25 Key Levels to Watch Amid Market Pressure Bluerock Acquisition Corp Unit BLRKU Holds Steady at 1002 Assessing the SPACs Current Support and Resistance Levels GPAct III Acquisition Corp GPAT Holds Steady at 1080 as SPAC Awaiting Next Catalyst Energy Vault Holdings NRGV Edges Higher Amid Renewed Interest in Energy Storage Solutions BayCom Corp BCML Edges Higher Holding Above Key Support After Modest Advance Icahn Enterprises IEP Holds Steady Near 755 as Trading Volume Remains Subdued Nexstar Media Group NXST Edges Lower Amid Cautious Trading Support and Resistance Levels in Focus Daxor Corporation DXR Holds Steady at 1082 as Shares Test Key Support Zone Vince Holding Corp VNCE Edges Higher Amid Consolidation Near Support SIMPPLE Ltd SPPL Edges Higher Amid Consolidation Near Key Resistance SEC Updates IPO Regulatory Framework What Market Participants Should Know PTN Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Loss Narrows Stock Advances Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline